eOD-GT8 60mer + Core-g28v2
Alternative Names: Core-g28v2 60mer mRNA Vaccine/eOD-GT8 60mer mRNA Vaccine; eOD-GT8 60mer mRNA Vaccine (mRNA-1644) + Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core)Latest Information Update: 13 Dec 2021
At a glance
- Originator International AIDS Vaccine Initiative
- Class AIDS vaccines; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I HIV infections
Most Recent Events
- 12 Nov 2021 Phase-I clinical trials in HIV infections (Prevention) in USA (IM) (NCT05001373)
- 17 Sep 2021 International AIDS Vaccine Initiative plans a phase I trial in HIV infections (In volunteers) (IM), in September 2021 (NCT05001373)
- 10 Aug 2021 Preclinical trials in HIV infections in USA (IM)